Editorial board

  • M. Dzhugashvilli – M.D., Ph.D., Instituto Madrileño de Oncología (Grupo Imo), Madrid (Spain) (Israel);
  • M. Gültekin – M.D., Instructor, Department of Radiation Oncology, Hacettepe University, Ankara (Turkey);
  • K. Narayan – MBBS, M.D., Ph.D., FRANZCR, A/Prof., Peter MacCallum Cancer Center (Australia);
  • M. Silbermann – M.D., Ph.D., Prof., Executive director of the Middle East Cancer Consortium (MECC) since (Israel);
  • M. Aliev – MD, prof., Acad. RAS, FSBI NMRRC of the Ministry of Health of the Russian Federation
    named after P.A. Herzen (Russia);
  • L. Dzhansugurova – Cand. of med. Sciences, associate. Prof., Institute of General Genetics and Cytology (Kazakhstan);
  • E. Imyanitov – MD, member-cor. RAS, Research Institute of Oncology named after N.N. Petrov (Russia);
  • A. Kaprin – MD, prof., Acad. RAS, FSBI NMRRC of the Ministry of Health of the Russian Federation
    named after P.A. Herzen (Россия);
  • I. Kokhreidze – MD, prof., OC “KIRONI”, Tbilisi State Medical University (Georgia);
  • S. Krasnyi – MD, prof., Member-cor. NASB, RSPCOMR named after N.N. Aleksandrova (Belarus);
  • V. Moiseenko – MD, Prof., SPb State budgetary health care institution “Oncological Center” (Russia);
  • I. Omarova – MD, prof., Karaganda ROD (Kazakhstan).
  • T. Semiglazova – MD, prof., Research Institute of Oncology named after N.N. Petrov (Russia);
  • I. Stilidi – MD, prof., Member-cor. RAS, Russian Cancer Research Center named after N.N. Blokhin (Russia);
  • E. Tilekov – MD, prof., NOC (Uzbekistan);
  • M. Tilliashaykhov – MD, prof., ROSC MH (Uzbekistan);
  • Z. Huseynov. – MD, ROSC (Tajikistan);

 

* The members of the Journal Editorial Team and Editorial Board were changed
according to the minutes of the meeting of the Academic Council No. 3 of 23.06.2020 г.

 
* The members of the Journal Editorial Team and Editorial Board were changed
according to the minutes of the meeting of the Academic Council No. 4 of 21.09.2020 г.






(.docx, .xlsx, .pdf, .rar, .zip)